Synta Pharmaceuticals Corp
SEC CIK 1157601 · SNTA · last insider filing 2026-06-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Baker Julian | Director | filed 2023 - 2026 |
| Baker Felix | Director | filed 2023 - 2026 |
| Baker Bros. Advisors LP | Director | filed 2023 - 2026 |
| Baker Brothers Life Sciences LP | Director | filed 2023 - 2026 |
| Fouse Jacqualyn A | Director | filed 2025 - 2026 |
| Taub Rebecca | Director · See Remarks | filed 2016 - 2026 |
| Levy Richard S | Director | filed 2016 - 2026 |
| 667, L.P. | Director | filed 2023 - 2026 |
| Daly James M | Director | filed 2019 - 2026 |
| Baker Bros. Advisors (GP) LLC | Director | filed 2023 - 2026 |
| Brennan Daniel J. | Director | filed 2025 - 2026 |
| Sibold William John | Director · President and CEO | filed 2023 - 2026 |
| Friedman Paul A | Director · Chief Executive Officer | filed 2014 - 2026 |
| Bate Kenneth | Director | filed 2016 - 2025 |
| Craves Fred B | Director | filed 2016 - 2025 |
| Cheong Raymond | Director | filed 2023 - 2023 |
| Milligan David V | Director | filed 2016 - 2022 |
| Gollust Keith R | Director | filed 2007 - 2022 |
| BAY City Capital LLC | Director | filed 2016 - 2021 |
| BAY City Capital Fund IV CO Invesment Fund LP | Director | filed 2016 - 2021 |
| Bay City Capital Management IV LLC | Director | filed 2016 - 2021 |
| Bay City Capital Fund IV, L.P. | Director | filed 2016 - 2021 |
| Schor Chen | Director · President and CEO | filed 2014 - 2016 |
| Morenstein Scott D | Director | filed 2015 - 2016 |
| Kovner Bruce | Director | filed 2007 - 2015 |
| Wilson Robert N | Director | filed 2007 - 2015 |
| Reardon William S | Director | filed 2007 - 2015 |
| Kufe Donald W | Director | filed 2010 - 2015 |
| Whitaker Anne Clem | Director · President and CEO | filed 2014 - 2015 |
| Bahcall Safi R | Director · President and CEO | filed 2007 - 2014 |
| Chen Lan Bo | Director | filed 2007 - 2013 |
| Folkman Judah | Director | filed 2007 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Soergel David | Chief Medical Officer | filed 2025 - 2026 |
| Dier Mardi | SVP and CFO | filed 2024 - 2026 |
| Huntsman Carole | Chief Commercial Officer | filed 2023 - 2026 |
| Kelley Shannon T | General Counsel | filed 2024 - 2026 |
| Thakkar Rita | Chief Accounting Officer | filed 2026 - 2026 |
| Waltermire Robert E. | Senior VP, Chief Pharma Dev. | filed 2021 - 2025 |
| Lynch Brian Joseph | See Remarks | filed 2019 - 2024 |
| Howarth Alex G. | Chief Financial Officer | filed 2021 - 2024 |
| Sukhija Remy | SVP and Chief Comm'l Officer | filed 2020 - 2023 |
| Schneebaum Marc R | SVP and CFO | filed 2014 - 2021 |
| Rieder Wendy E | VP, IP and Legal, Gen. Counsel | filed 2007 - 2016 |
| Vukovic Vojo | SVP, Chief Medical Officer | filed 2009 - 2015 |
| Mcmahon Arthur | SVP, People Operations | filed 2014 - 2015 |
| Ehrlich Keith S | VP, Fin. and Admin., CFO | filed 2007 - 2014 |
| Singh Amar | Sr. VP, Chief Business Officer | filed 2010 - 2014 |
| Bernitz Steven B | SVP, Corporate Development | filed 2013 - 2013 |
| Ramachandra Sumant | President, R&D | filed 2013 - 2013 |
| Koya Keizo | Sr. VP, Drug Development | filed 2007 - 2012 |
| Bailey Michael P | Sr. VP, Chief Comm. Officer | filed 2008 - 2010 |
| Chadwick Jeremy G | Sr. VP, Program Mgmt and Ops | filed 2007 - 2010 |
| Barsoum James G | Sr. VP, Research | filed 2007 - 2009 |
| Jacobson Eric W | Sr. VP, Research and CMO | filed 2007 - 2009 |
| Williams Martin D | Sr. VP, Business Dev., CBO | filed 2007 - 2008 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.